Navigation Links
Viral 'fitness' explains different resistance patterns to aids drugs

f adherence. This happens because only a single mutation is required to create high-level NNRTI resistance and these mutations have little impact on the virus's ability to replicate. PI-resistant virus, in contrast, requires multiple mutations, each of which significantly weakens the ability of the virus to replicate. These PI-resistant viruses only emerge, therefore, when challenged with high concentrations of drug.

Overall, study findings showed that NNRTI resistance was found less often than PI resistance among patients who took the pills as directed.

"We believe that when new drug classes are developed, more attention should be given in defining how virologic fitness determines how different patterns of taking medications may lead to resistance" said Steven Deeks, MD, associate professor of medicine at UCSF's Positive Health Program at SFGHMC and senior author on the study.

Both NNRTIs and non-boosted protease inhibitors are potent antiretroviral drugs (ARVs) with demonstrated effectiveness in suppressing the HIV virus when taken in combination with other ARVs at high levels of pill-taking as directed. The standard combination therapy usually includes either one NNRTI or protease inhibitor (non-boosted or boosted with a small amount of another potent PI) and two different antiretrovirals from the nucleoside reverse transcriptase inhibitor class.


'"/>

Source:University of California - San Francisco


Page: 1 2

Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
3. Viral protein influences key cell-signaling pathway
4. Viral protein helps infected T cells stick to uninfected cells
5. Viral genetic differences are possible key to HIV dementia
6. Viral hitchhiker inhibits Wolbachia bacterias ability to proliferate
7. Viral marker of human migration suspect
8. Viral protein is an effective preventative against infection
9. Gene sequencing explains bioremediation bug
10. New book explains antibiotic resistance for a broad audience
11. UGA study explains peaks and troughs of dengue epidemics

Post Your Comments:
(Date:11/24/2009)...rican College of Medical Toxicology (ACMT) have si...n of the Journal of Medical Toxicology (JMT), th... 2010. It was previously published by the Univers...dical Toxicology , an international, peer-reviewed...d practice of medical toxicology. The quarterly j...
(Date:11/24/2009)...sh food is a matter of debate. A high-profile stud...0 percent of their carbon from trees and leaves, e...ial and aquatic ecosystems. , But new research f... likely to be true. Algae provide a much richer di...esearch published this week in the Proceedings of...
(Date:11/23/2009)...ch presents strong evidence that the "synergistic"...ffic-related pollution and indoor endotoxin causes...er exposure alone. , Environmental health scie...e of Medicine have shown that children exposed to ...indoor endotoxin during early life are six times m...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 1CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 2CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 3Women More Likely Than Men to Reject Unattractive Babies 49890 1Women More Likely Than Men to Reject Unattractive Babies 49890 210th CyberKnife System Installed at an HCA Hospital 49885 110th CyberKnife System Installed at an HCA Hospital 49885 210th CyberKnife System Installed at an HCA Hospital 49885 310th CyberKnife System Installed at an HCA Hospital 49885 4
...t Melbourne,s Howard Florey Institute have found a...ying after experiencing traumatic brain injury fro...s. , The team, led by Professor Seong-Seng Tan, h..., called BP5, is produced more than usual in brain...y. , Prof Tan said that because this protein is...
...t the U.S. Department of Energy,s Brookhaven Natio...nter, and SGX Pharmaceuticals, Inc., have determin...hanism of an enzyme essential for eliminating unwa...ustrial chemicals, and toxic compounds from the bo...entists understand how these compounds are elimina...
...ants of a simple sugar ameliorate Alzheimer,s-like...dian researchers. Although the new studies are sti... new therapies that prevent or delay the onset of ...ome types of a sugar called cyclohexanehexol--also...amyloid รข deposits, a hallmark of Alzheimer,s dise...
Other Biology News:New research promising for improving brain cell survival after brain injury 2Scientists take 'snapshots' of enzyme action 2A sweet solution for Alzheimer's disease? 2A sweet solution for Alzheimer's disease? 3
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--NeogenCorporation(Nasd...,waselectedtoNeogen,sBoardofDirectorsatthecompany,...asmorethan40yearsofexperienceinthefood,agriculture...ofessorofagriculturaleconomicsatVirginiaTechUniver...tateschiefagriculturenegotiatorwiththerankofambass...
(Date:11/23/2009)...3/PRNewswire/-InimexPharmaceuticals,Inc.announcedt...sidentandCEO. ,, Abramsbringsmorethan25yearsofd...co-inventorofthenuclearmedicineimagingagent,Cardio...erehewasManager,BiomedicalResearchWorldwide.In1996...wasPresidentandCEOfrom1996to2006.AnorMEDdiscovered...
(Date:11/23/2009).../PRNewswire-FirstCall/--CornerstoneTherapeuticsInc...cusedonacquiring,developingandcommercializingsigni...markets,todayannouncedthatCraigA.Collard,President...eoverviewatthe21stAnnualPiperJaffrayHealthCareConf...YorkPalaceHotelinNewYorkCity. ,, Aliveaudioanda...
(Date:11/20/2009)...v. 20 Veridiam (www.veridiam.com) ...company category at the 2009 Workplace Excellence ...Society for Human Resources Management and recogni...tices. ,, Veridiam was one of nine winners, sel...ies, honored at the recent awards ceremony. San Di...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Inimex Announces Appointment of New CEO 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...WALTHAM, Mass., March 18 Inverness Medical,Innova...and marketer of rapid,diagnostic products for the ... that as part of its continuing efforts to streaml...wering operating costs and improving,margins, it h...the San,Francisco area which currently house its C...
...Toronto Stock Exchange Symbol: MS, EDMONTON, Marc...(TSX:,MS), a leading developer in the treatment of...al and operational results for the year ended,Dece...dwide development of MBP8298, our,proprietary synt...clerosis,which is being evaluated in several late-...
...Boam to address venture capitalists and venture-ba...FDA regulation of medical devices, ST. LOUIS PARK...e organizer International Business Forum (IBF) and...n of medical device and other,biotechnology firms,...irector for Science and Review Policy, Office of D...
Other Biology Technology:Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities 2Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities 3BioMS Medical Announces 2007 Year End Results 2BioMS Medical Announces 2007 Year End Results 3BioMS Medical Announces 2007 Year End Results 4BioMS Medical Announces 2007 Year End Results 5IBF/LifeScience Alley MedTech Investing Conference Adds Ashley Boam, Acting Deputy Director for Science and Review Policy, Office of Device Evaluation, Center for Devices and Radiological Health, FDA 2
...unogen Synthetic peptide: QAARQAATSVPNPP, corresp...BRF2. Reactivity / Specificity Cross-reacts with...nd Information BRF2 is one of the multiple subuni...complex required for transcription of genes with p...
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Anti-alpha/beta-Tubulin Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: